| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |